Chen Yu jumps ship from Vivo Capital and goes large, allying with The Column Group on an inaugural $824M biotech crossover fund

Over the past 15 years, the crew at The Column Group have gathered more than $2 billion together to pursue their game plan of fostering …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Chen Yu jumps ship from Vi­vo Cap­i­tal and goes large, al­ly­ing with The Col­umn Group on an in­au­gur­al $824M biotech crossover fund